A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

Clinical trial NCT06849258 · RECRUITING

Trial details

NCT number: NCT06849258
Sponsor: Rivermark Medical
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2025-02-10
Primary completion: 2032-12-31
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.